157 related articles for article (PubMed ID: 21641721)
1. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
Andrade HM; Toledo VP; Pinheiro MB; Guimarães TM; Oliveira NC; Castro JA; Silva RN; Amorim AC; Brandão RM; Yoko M; Silva AS; Dumont K; Ribeiro ML; Bartchewsky W; Monte SJ
Vet Parasitol; 2011 Sep; 181(2-4):83-90. PubMed ID: 21641721
[TBL] [Abstract][Full Text] [Related]
2. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol.
Manna L; Reale S; Picillo E; Vitale F; Gravino AE
Cytokine; 2008 Nov; 44(2):288-92. PubMed ID: 18842424
[TBL] [Abstract][Full Text] [Related]
4. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
6. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
Gravino AE
Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
[TBL] [Abstract][Full Text] [Related]
7. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
[TBL] [Abstract][Full Text] [Related]
9. Acute phase protein response in experimental canine leishmaniasis.
Martinez-Subiela S; Strauss-Ayali D; Cerón JJ; Baneth G
Vet Parasitol; 2011 Aug; 180(3-4):197-202. PubMed ID: 21511399
[TBL] [Abstract][Full Text] [Related]
10. Splenic immune responses during canine visceral leishmaniasis.
Strauss-Ayali D; Baneth G; Jaffe CL
Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
[TBL] [Abstract][Full Text] [Related]
11. Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine.
Manna L; Gravino AE; Picillo E; Decaro N; Buonavoglia C
Ann N Y Acad Sci; 2008 Dec; 1149():358-60. PubMed ID: 19120249
[TBL] [Abstract][Full Text] [Related]
12. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs.
Sanchez-Robert E; Altet L; Alberola J; Rodriguez-Cortés A; Ojeda A; López-Fuertes L; Timon M; Sanchez A; Francino O
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):168-75. PubMed ID: 18514330
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
15. Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
Reimão JQ; Oliveira JC; Trinconi CT; Cotrim PC; Coelho AC; Uliana SR
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003556. PubMed ID: 25679212
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum.
Gonçalves G; Campos MP; Gonçalves AS; Figueiredo FB
Rev Bras Parasitol Vet; 2024; 33(1):e015023. PubMed ID: 38359300
[TBL] [Abstract][Full Text] [Related]
17. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
Pasa S; Toz SO; Voyvoda H; Ozbel Y
Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and transcription factor profiles in the skin of dogs naturally infected by Leishmania (Leishmania) chagasi presenting distinct cutaneous parasite density and clinical status.
Menezes-Souza D; Corrêa-Oliveira R; Guerra-Sá R; Giunchetti RC; Teixeira-Carvalho A; Martins-Filho OA; Oliveira GC; Reis AB
Vet Parasitol; 2011 Apr; 177(1-2):39-49. PubMed ID: 21163578
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnosis of canine visceral leishmaniasis: identification of Leishmania species by PCR-RFLP and quantification of parasite DNA by real-time PCR.
Quaresma PF; Murta SM; Ferreira Ede C; da Rocha-Lima AC; Xavier AA; Gontijo CM
Acta Trop; 2009 Sep; 111(3):289-94. PubMed ID: 19467216
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
